Thousands Sue for Damages Against Cholesterol Drugs as Big Pharma Defends Billion Dollar Industry: Report
The USD100 billion dollar cholesterol-lowering statin drug industry is under attack, as thousands of Americans are filing lawsuits against the manufacturers of cholesterol-lowering drugs such as Lipitor. Research continues to confirm just how dangerous these drugs are, with yet another study published recently linking increased statin drug use to type 2 diabetes, says a report.
Since the study was published by the American Diabetes Association, the report says, these known risks to cholesterol-lowering drugs can no longer be denied or defended, and the lawsuits are pouring in at a rapid pace. Most of the lawsuits at this point are from women who have suffered with diabetes as a result of taking cholesterol-lowering drugs, but lawsuits over breast cancer, Alzheimer’s, liver damage, and others may soon follow now that it is generally known how dangerous these drugs are.
This information regarding a tsunami
of lawsuits against cholesterol drug manufacturers has yet to be widely published by the mainstream media, however. To find out the magnitude of the lawsuits being filed against statin drug manufacturers, we turn to law firms who are reaping the fruit of litigation against Big Pharma, Brian Shilhavy of Health Impact News says in the report
"According to statistics supplied by various law firms, there were 464 claims filed against Lipitor as of April 15, 2014, which increased to 703 by May 15, and then to 846 by June 16. By mid-July 2014 over 959 claims have been filed for damages due to Lipitor alone, and that increased in August to 1162. There are also many claims currently filed against Crestor, the next nearest competitor to Lipitor, and undoubtedly other similar drugs now sold under generic labels. These lawsuits now number well over 1,200, and are increasing at a rapid pace."
Lipitor is by far the most profitable drug in the history of mankind among all pharmaceutical products, let alone being the most profitable cholesterol drug before its patent expired at the end of 2011. Sales to date from this one particular cholesterol-lowering statin drug have exceeded $140 billion.
Last year, Professor Dr BM Hegde, a Padma Bhushan awardee, wrote in his column in Moneylife about multiple side effects of statins. He says, “Statins are the most sold, most talked about, yet, the most dangerous chemicals, used in Western medical therapeutics only to get a ‘better’ lipid profile report of hapless, unsuspecting humans—dubbed as patients—, because they have lots of patience to bear with all the physical insults that we inflict on them.”
“Truth, unfortunately, is very lazy. By the time truth could pull up its pants to start the race, falsehood and mystery will have gone round the globe twice over! We might break our heads; but the powerful pharma lobby will prevail, truth notwithstanding. God save mankind from this unholy nexus between the drug manufacturers, the medical profession and the regulatory agencies. Thank God, the industry has not succeeded in getting statins put into drinking water supplies! However, they have put it into the controversial poly-pill—an alleged Rambaana
(panacea) for all ills. Let’s hope for that utopia where truth prevails,” Prof Dr Hegde wrote. (Read: Stop those Statins!
Lipitor benefited from the change in marketing laws in 1997 that allowed pharmaceutical companies in the U.S. to advertise their products directly to consumers. Pfizer convinced an entire generation of Americans that they needed a pill to lower their cholesterol in order to prevent heart disease, in what will go down as one of the most brilliant and unethical marketing schemes of all time.
After Lipitor’s patent expired at the end of 2011, the FDA issued its first warnings against statin drugs, which includes: liver injury, memory loss, diabetes, and muscle damage. Soon after issuing these warnings, the lawsuits started trickling in. Today, with more and more studies being published linking statin drug use to various side effects, those lawsuits have become a tidal wave, even though you are not likely to hear about this in the mainstream media.
Big Pharma Fights Back – They Do Not Want you to Know Cholesterol Drugs are Worthless and Dangerous
As is often the case when learning about the criminal activities of Big Pharma, much of the research is conducted outside of the U.S. The above referenced study published recently by the American Diabetes Association, for example, was conducted in Italy.
Since the patent on Lipitor has expired, pharmaceutical companies have been searching for the next big blockbuster cholesterol drug to bring in profits like Lipitor did. One of these newer cholesterol-lowering drugs is U.S.-made Zetia by Merck. Alberto Donzelli, head of education, appropriateness, and evidence-based medicine at Milan’s public health authority in Italy, has issued warnings about the dangers of this drug, and advised doctors in Italy not to prescribe it. Merck responded with two cease-and-desist orders and the threat of suing Donzelli. Donzelli backed down, but Merck has received a lot of public pressure in Europe since the story was picked up by the British Medical Journal. It was also reported in the Wall Street Journal here in the U.S. When doctors and medical professionals oppose Big Pharma, they put their careers and sometimes their lives on the line.... Continue Reading....
You may also want to read…